Michael P. Tarnok's Net Worth
$89.3 Thousand
Who is Michael P. Tarnok?
Michael P. Tarnok does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DYADIC INTERNATIONAL INC, and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
Michael P. Tarnok's CIK is 0001413525
Past Insider Trading and Trends
2024 was Michael P. Tarnok's most active year for acquiring shares with 6 total transactions. Michael P. Tarnok's most active month to acquire stocks was the month of May. 2024 was Michael P. Tarnok's most active year for disposing of shares, totalling 6 transactions. Michael P. Tarnok's most active month to dispose stocks was the month of April. 2015 saw Michael P. Tarnok paying a total of $97,300.00 for 50,000 shares, this is the most they've acquired in one year. In 2024 Michael P. Tarnok cashed out on 94,730 shares for a total of $40,799.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DYADIC INTERNATIONAL INC (DYAI) Snapshot price: $1.3
InvestorMichael P. Tarnok owns 221,672 units of Common Stock which is worth $288,173.60. From 2019 to 2024 Michael P. Tarnok acquired a total of 57,174 shares in DYADIC INTERNATIONAL INC at a cost of $40,800.00, Michael also disposed a total of 24,431 shares of DYADIC INTERNATIONAL INC equalling to $40,799.77.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.58% | 5.57K |
$1.52 | $0.23 | 221.67K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
| +14.38% | 27.17K |
—
|
—
| 216.1K |
Jan 2 - Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KERYX BIOPHARMACEUTICALS INC No price found
Interim CEOMichael P. Tarnok owns 338,600 units of Common stock. From 2007 to 2015 Michael P. Tarnok acquired a total of 313,600 shares in KERYX BIOPHARMACEUTICALS INC at a cost of $198,906.00, Michael also disposed a total of 25,000 shares of KERYX BIOPHARMACEUTICALS INC.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.04% | 10K |
—
|
—
| 338.6K |
Jun 17
| |||
Form 4
| +3.14% | 10K |
$9.73 | $97,300.00 | 328.6K |
May 6
| |||
Form 4
| -3.04% | -10.00K |
—
|
—
| 318.6K |
Jun 24
| |||
Form 4
| -4.64% | -15.00K |
—
|
—
| 308.6K |
Jun 19
| |||
Form 4
| +5.38% | 15K |
—
|
—
| 293.6K |
Jun 20
| |||
Form 4
| +6.70% | 17.5K |
$1.55 | $27,125.00 | 278.6K |
Apr 5
| |||
Form 4
| +6.10% | 15K |
$3.10 | $46,500.00 | 261.1K |
Aug 10
| |||
Form 4
| +6.49% | 15K |
—
|
—
| 246.1K |
Jun 22 - Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4
| +6.94% | 15K |
—
|
—
| 231.1K |
Jun 16
| |||
Form 4
| +13.08% | 25K |
—
|
—
| 216.1K |
Jun 16 - Jun 17
| |||
Form 4
| +26.47% | 40K |
$0.46 | $18,400.00 | 191.1K |
May 26
| |||
Form 4
| +195.69% | 100K |
—
|
—
| 151.1K |
Apr 29
| |||
Form 4
| +4,545.45% | 50K |
—
|
—
| 51.1K |
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
∞
| 1.1K |
$8.71 | $9,581.00 | 1.1K |
Nov 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||